CPHA Canvax
CPHA Canvax

Seasonal Influenza 2020-2021 Recommendations in the Context of COVID-19

Organization: National Collaborating Centre for Infectious Diseases (NCCID)
 Published: 2020
Bookmark

"Learn about this year’s recommendations for the prevention and treatment of seasonal influenza, the use of antivirals, the recommended vaccinations, and infection and prevention control measures to reduce the risk of COVID-19 transmission at the time of flu vaccine administration." - Seasonal Influenza 2020-2021 Recommendations in the Context of COVID-19

For additional information and presenter slides, visit the link below.  

Seasonal Influenza 2020-2021 Recommendations in the Context of COVID-19
Author(s): Ian Gemmill, Robyn Harrison , Gerald Evans Rating See Comments Ratings
Resource Group: Background Knowledge
 Product Type: Webinar

Category:

Program Planning and Delivery,Program Delivery and Evaluation,Clinics,Vaccine Preventable Diseases,Communicable Diseases,Influenza Program Planning and Delivery
Program Delivery and Evaluation
Clinics
Vaccine Preventable Diseases
Communicable Diseases
Influenza
Audience: Health Care Professional
 Population: Adults
Children (All)
Pregnant and Breastfeeding People
Seniors
 Region: National
Language: English
PDF

Summary of National Advisory Committee on Immunization (NACI) Statement of February 2023: Public Health Level Recommendations on the Use of Pneumococcal Vaccines in Adults, Including the Use of 15-Valent and 20-Valent Conjugate Vaccines

Organization: Public Health Agency of Canada (PHAC) Published: 2023
PDF

Guidance on an additional COVID-19 booster dose in the spring of 2023 for individuals at high risk of severe illness due to COVID-19

Organization: Public Health Agency of Canada (PHAC) Published: 2023
PDF

Interim guidance on the use of pneumococcal 15-valent conjugate vaccine (PNEU-C-15) in pediatric populations

Organization: Public Health Agency of Canada (PHAC) Published: 2023

0 Comments

Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.

All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.

Login or register to comment